Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer
| dc.contributor.author | Simoes, Ana Rita | |
| dc.contributor.author | Carlés González, Silvia | |
| dc.contributor.author | López Doldan, María del Carmen | |
| dc.contributor.author | Duran, Goretti | |
| dc.contributor.author | Fernández Montes, Ana | |
| dc.contributor.author | Fernández, María Perfecta | |
| dc.contributor.author | Salgado Fernández, Mercedes | |
| dc.contributor.author | García Mata, Jesús | |
| dc.contributor.author | Páez, David | |
| dc.contributor.author | López Aspiroz, Elena | |
| dc.contributor.author | et al. | |
| dc.date.accessioned | 2025-10-10T13:28:59Z | |
| dc.date.available | 2025-10-10T13:28:59Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Chemotherapeutic treatment for colorectal cancer (colorectal cancer) allows for increasedpatient overall survival. However, current therapeutic regimens are often associated with the development of adverse drug reactions, which represent amorbidity, mortality and economic issue. We propose to identify novel germ line markers that allow usto predict adverse drug reactions development after colorectal cancer chemotherapy. Overall, the present work has utilised state-of-the-art approaches to uncover several novel candidate toxicity variants/genes. | |
| dc.description.filiation | UEM | |
| dc.description.impact | 7.7 Q1 JCR 2024 | |
| dc.description.impact | 2.344 Q1 SJR 2024 | |
| dc.description.impact | No data IDR 2023 | |
| dc.description.sponsorship | Ver financiación en http://doi.org/10.1111/bph.70051 | |
| dc.identifier.citation | Simoes, A. R., Carlés González, S., Lopez‐Doldan, M. D. C., Duran, G., Fernández‐Montes, A., Fernandez, M. P., Salgado Fernandez, M., Garcia Mata, J., Paez, D., Riera, P., Guino, E., Lopez‐Fernandez, L., Garcia De Santiago, B., López Aspiroz, E., Rojas, A., Castells, A., Castellvi‐Bel, S., Ruiz Ponte, C., Vymetalkova, V., … Fernandez‐Rozadilla, C. (2025). Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer. British Journal of Pharmacology, 182(21), 5340-5354. https://doi.org/10.1111/bph.70051 | |
| dc.identifier.doi | 10.1111/bph.70051 | |
| dc.identifier.issn | 0007-1188 | |
| dc.identifier.uri | https://hdl.handle.net/11268/16374 | |
| dc.language.iso | eng | |
| dc.peerreviewed | Si | |
| dc.relation.publisherversion | http://doi.org/10.1111/bph.70051 | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.accessRights | open access | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.other | Farmacogenética | |
| dc.subject.other | Quimioterapia | |
| dc.subject.other | Neoplasias Colorrectales | |
| dc.subject.sdg | Goal 4: Quality education | |
| dc.subject.sdg | Goal 3: Ensure healthy lives and promote well-being for all at all ages | |
| dc.subject.unesco | Ciencias médicas | |
| dc.subject.unesco | Genética humana | |
| dc.subject.unesco | Farmacología | |
| dc.title | Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer | |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- British J Pharmacology - 2025 - Simoes - Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity (1).pdf
- Size:
- 1.61 MB
- Format:
- Adobe Portable Document Format

